ETF DAILY NEWS

FY2025 EPS Estimates for Verona Pharma Raised by Analyst

Verona Pharma plc (NASDAQ:VRNA – Free Report) – Stock analysts at Cantor Fitzgerald lifted their FY2025 earnings per share (EPS) estimates for Verona Pharma in a report issued on Wednesday, June 11th. Cantor Fitzgerald analyst O. Brayer now forecasts that the company will post earnings of $0.14 per share for the year, up from their […]

Jun 15, 2025 - 07:20
 0
FY2025 EPS Estimates for Verona Pharma Raised by Analyst
Verona Pharma plc (NASDAQ:VRNA – Free Report) – Stock analysts at Cantor Fitzgerald lifted their FY2025 earnings per share (EPS) estimates for Verona Pharma in a report issued on Wednesday, June 11th. Cantor Fitzgerald analyst O. Brayer now forecasts that the company will post earnings of $0.14 per share for the year, up from their […]
Read More

Tags:

Previous Article

What is Raymond James’ Forecast for CVE:BLN Q3 Earnings?

Next Article

Q2 EPS Estimates for OTCMKTS:CPKF Raised by Zacks Small Cap

Related Posts

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $1.77 Million Holdings in iShares Russell 2000 ETF (NYSEARCA:IWM)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT...

Jun 8, 2025  0

Q2 EPS Estimates for Teladoc Health Lifted by Zacks Research

Q2 EPS Estimates for Teladoc Health Lifted by Zacks Res...

May 20, 2025  0

nCino (NASDAQ:NCNO) Receives “Market Outperform” Rating from JMP Securities

nCino (NASDAQ:NCNO) Receives “Market Outperform” Rating...

May 28, 2025  0